Navigation Links
Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting

etic mechanisms co-operate to silence key tumor suppressor genes in cancer, we are able to choose epigenetic drugs from within our portfolio to combine and attack these silencing systems simultaneously, with encouraging clinical data emerging in the context of acute myeloid leukemia."

Pharmion has three epigenetic products in its portfolio, including Vidaza(R) (azacitidine for injection), MGCD0103 and oral Azacitidine. Pharmion currently markets Vidaza, its parenteral formulation of Azacitidine, in the U.S. and several additional countries for the treatment of patients with MDS. Abstracts presented at this year's ASCO meeting will address the pharmacokinetics of oral Azacitidine administration, and report data from studies investigating Vidaza's utility in MDS, including alternative dosing schedules and in the treatment of MDS patients with marrow fibrosis.

Additionally, accepted abstracts will investigate the use of Vidaza as part of combination treatment regimens with other epigenetic therapies, including interim results from an ongoing study with MGCD0103, for the treatment of high-risk MDS and acute myeloid leukemia (AML), and in combination with valproic acid in advanced solid tumors.

An oral presentation on a study of MGCD0103 in relapsed/refractory Hodgkin's lymphoma will be presented during ASCO, as will a poster on the use of MGCD0103 as a single agent in patients with MDS or leukemias. Pharmion has a licensing and collaboration agreement with MethylGene for MGCD0103, as well as MethylGene's pipeline of second-generation HDAC inhibitor compounds for oncology indications.

Data from a first-line study evaluating the addition of Thalidomide to the standard of care for elderly multiple myeloma patients will be the subject of an oral presentation at the 2007 ASCO meeting, where a total of three oral presentations and six posters on Thalidomide studies will be presented. Data from the oral presentation reinforce the substantial body of
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:5/1/2015)... Colo. , May 1, 2015   Heska Corporation ... or the "Company"), a provider of advanced veterinary diagnostic ... Robert Grieve , Executive Chair, will present at the 16th ... (PT), on May 13, 2015. The conference will be held ... Angeles, CA. Heska management will be available during ...
(Date:5/1/2015)... 2015 The Institute for Healthcare Advancement (IHA) ... winners. The IHA Health Literacy Awards aim to encourage, ... the practice of educating or empowering organizations to deliver ... in three categories: innovative programs, published materials and research. ... award. In the area of innovative programs, ...
(Date:5/1/2015)... N.Y. , May 1, 2015  Misonix, ... device company that designs, manufactures and markets innovative ... neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and ... report financial results for the third quarter fiscal ... Company has scheduled a conference call that same ...
Breaking Medicine Technology:Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2Institute for Healthcare Advancement Announces 2015 Award Winners 2Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2
... Arthroscopic Surgery Successful in Active Patients For Over ... Young, athletic, first-time,shoulder dislocation patients benefit from arthroscopic ... at the 2008 American Orthopaedic,Society for Sports Medicine ... that for highly active patients, surgery, rather than ...
... 7 AlphaMed Pharmaceuticals,Corporation announced today that the ... therapeutic protein alpha 1-antitrypsin (AAT).,AlphaMed scientists expressed their ... yeast. The yeast has been genetically,altered to produce ... by the human body., "This marks a ...
Cached Medicine Technology:Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term 2Controversial Shoulder Surgery for First-time Dislocation Proven Effective Long-Term 3AlphaMed Pharmaceuticals Announces Breakthrough in the Development of Recombinant Alpha 1-Antitrypsin 2
(Date:5/2/2015)... May 02, 2015 ZoomCare, the Portland-based ... submitted plans to offer its new healthcare insurance to ... ZOOM+ Personal Health Insurance System is the nation’s first ... enhance human performance. ZOOM+ Personal Health Insurance was ZoomCare’s ... system that are subject to review and regulation by ...
(Date:5/1/2015)... Pioneer Millworks, the largest reclaimed wood ... their reclaimed wood products at the 27th annual International ... in NYC this May. Their newest offerings, Vat 35, ... texture and color to North America's platform for global ... and color in the design world and we're excited ...
(Date:5/1/2015)... 2015 TROY Healthcare Solutions is proud ... User Group (RUG) Conference in Atlanta, GA from May ... Group Conference provides a forum for client-to-client presentations, continuing ... aspects of electronic medical record operations, as well as ... , In addition to sponsoring the event, TROY Healthcare ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 The fields ... makeup and the interplay of genes with one another ... developments can be daunting. , LabRoots, the premier producer ... diagnostics professionals, will soon host its annual conference spotlighting ... BioConference Live Genetics and Genomics 2015 , a ...
(Date:5/1/2015)... D.C. (PRWEB) May 01, 2015 Digital ... and manage pregnant women between prenatal appointments, a ... study, of a small sample of low-risk pregnant women, ... The George Washington University Medical Faculty Associates at the ... Clinical and Scientific Meeting, May 2-6. The digital technology ...
Breaking Medicine News(10 mins):Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 3
... at the University of Illinois at Chicago, in collaboration with ... precisely how the antibiotic linezolid inhibits bacterial growth. ... first new antibiotic to enter the marketplace in 30 years ... of the cell. But exactly where the binding occurred and ...
... Andhra Pradesh Chief Minister Y.S. Rajasekhara Reddy, who is ... University to set up an offshore campus in Hyderabad, ... ,The chief minister made the request after the signing ... and Satyam Computers' EMRI (Emergency Management and Research Institute) ...
... say they have developed a technique to attack and ... as nausea or hair loss. ,They ... attack cancer cells, but leave healthy tissue unaffected. ... with anti-cancer antibodies so they zero in on their ...
... struck Salisbury, suburb north of the Adelaide capital of the ... kid , sliding down in a popular playground, came into ... is not clear what happened to the kid, but a ... gone wrong. ,Health authorities described the chemical as ...
... People with HIV who drop out of care do not ... treatment, said Baylor College of Medicine and Veterans Affairs ... of Clinical Infectious Diseases and available on line. ... (the human immunodeficiency virus that causes AIDS) is keeping people ...
... artificial plastic blood, which they claim could act as a ... in war zones. ,The new artificial blood ... atom at their core, like haemoglobin, that can carry oxygen ... looking for extra funding to develop a final prototype that ...
Cached Medicine News:Health News:Researchers Discover How Antibiotic Inhibits Bacterial Growth 2Health News:Reddy Asks Stanford University to Open Hyderabad Campus 2Health News:New Cancer Therapy That can Be Less Painful 2Health News:Children Using Slide in Playground Treated for Exposure to Poisoning 2Health News:HIV Survival Improves If Patients Stay in Care 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: